Report Detail

Service & Software Global Gene Subcloning Service Market Research Report 2022

  • RnM4490377
  • |
  • 14 September, 2022
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Service & Software

Highlights

The global Gene Subcloning Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Gene Subcloning Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Gene Subcloning Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The global market for Gene Subcloning Service in Academic and Research Institutions is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global companies of Gene Subcloning Service include Thermo Fisher Scientific, Eurofins Scientific, Merck KGaA, Genscript Biotech Corp, Synbio Technologies, Bio Basic, Bioneer Corporation, Applied Biological Materials and Takara Bio, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

Considering the economic change due to COVID-19, Stranded Gene, which accounted for % of the global market of Gene Subcloning Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Subcloning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Subcloning Service.

The Gene Subcloning Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Gene Subcloning Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Subcloning Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher Scientific

Eurofins Scientific

Merck KGaA

Genscript Biotech Corp

Synbio Technologies

Bio Basic

Bioneer Corporation

Applied Biological Materials

Takara Bio

Canvax Biotech

Codex DNA

Azenta US

Macrogen

InvivoGen

BioCat GmbH

BEX Co., Ltd

Lonza Group

Product Type Insights

Global markets are presented by Gene Subcloning Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Gene Subcloning Service are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Gene Subcloning Service segment by Type

Stranded Gene

Complex Gene

Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Gene Subcloning Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Gene Subcloning Service market.

Gene Subcloning Service Segment by Application

Academic and Research Institutions

Clinical Laboratories

Pharmaceutical and Biotechnology Companies

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Gene Subcloning Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Subcloning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Gene Subcloning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Gene Subcloning Service industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Subcloning Service.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gene Subcloning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue and gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global Gene Subcloning Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Stranded Gene
  • 1.2.3 Complex Gene
  • 1.2.4 Others
  • 1.3 Market by Application
  • 1.3.1 Global Gene Subcloning Service Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Academic and Research Institutions
  • 1.3.3 Clinical Laboratories
  • 1.3.4 Pharmaceutical and Biotechnology Companies
  • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Gene Subcloning Service Market Perspective (2017-2028)
    • 2.2 Gene Subcloning Service Growth Trends by Region
    • 2.2.1 Gene Subcloning Service Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Gene Subcloning Service Historic Market Size by Region (2017-2022)
  • 2.2.3 Gene Subcloning Service Forecasted Market Size by Region (2023-2028)
  • 2.3 Gene Subcloning Service Market Dynamics
  • 2.3.1 Gene Subcloning Service Industry Trends
  • 2.3.2 Gene Subcloning Service Market Drivers
  • 2.3.3 Gene Subcloning Service Market Challenges
  • 2.3.4 Gene Subcloning Service Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Gene Subcloning Service Players by Revenue
    • 3.1.1 Global Top Gene Subcloning Service Players by Revenue (2017-2022)
  • 3.1.2 Global Gene Subcloning Service Revenue Market Share by Players (2017-2022)
  • 3.2 Global Gene Subcloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Subcloning Service Revenue
  • 3.4 Global Gene Subcloning Service Market Concentration Ratio
  • 3.4.1 Global Gene Subcloning Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene Subcloning Service Revenue in 2021
  • 3.5 Gene Subcloning Service Key Players Head office and Area Served
  • 3.6 Key Players Gene Subcloning Service Product Solution and Service
  • 3.7 Date of Enter into Gene Subcloning Service Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Gene Subcloning Service Breakdown Data by Type

    • 4.1 Global Gene Subcloning Service Historic Market Size by Type (2017-2022)
    • 4.2 Global Gene Subcloning Service Forecasted Market Size by Type (2023-2028)

    5 Gene Subcloning Service Breakdown Data by Application

    • 5.1 Global Gene Subcloning Service Historic Market Size by Application (2017-2022)
    • 5.2 Global Gene Subcloning Service Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Gene Subcloning Service Market Size (2017-2028)
    • 6.2 North America Gene Subcloning Service Market Size by Country (2017-2022)
    • 6.3 North America Gene Subcloning Service Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Gene Subcloning Service Market Size (2017-2028)
    • 7.2 Europe Gene Subcloning Service Market Size by Country (2017-2022)
    • 7.3 Europe Gene Subcloning Service Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Gene Subcloning Service Market Size (2017-2028)
    • 8.2 Asia-Pacific Gene Subcloning Service Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Gene Subcloning Service Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Gene Subcloning Service Market Size (2017-2028)
    • 9.2 Latin America Gene Subcloning Service Market Size by Country (2017-2022)
    • 9.3 Latin America Gene Subcloning Service Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Gene Subcloning Service Market Size (2017-2028)
    • 10.2 Middle East & Africa Gene Subcloning Service Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Gene Subcloning Service Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Detail
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Gene Subcloning Service Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.1.5 Thermo Fisher Scientific Recent Development
  • 11.2 Eurofins Scientific
  • 11.2.1 Eurofins Scientific Company Detail
  • 11.2.2 Eurofins Scientific Business Overview
  • 11.2.3 Eurofins Scientific Gene Subcloning Service Introduction
  • 11.2.4 Eurofins Scientific Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.2.5 Eurofins Scientific Recent Development
  • 11.3 Merck KGaA
  • 11.3.1 Merck KGaA Company Detail
  • 11.3.2 Merck KGaA Business Overview
  • 11.3.3 Merck KGaA Gene Subcloning Service Introduction
  • 11.3.4 Merck KGaA Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.3.5 Merck KGaA Recent Development
  • 11.4 Genscript Biotech Corp
  • 11.4.1 Genscript Biotech Corp Company Detail
  • 11.4.2 Genscript Biotech Corp Business Overview
  • 11.4.3 Genscript Biotech Corp Gene Subcloning Service Introduction
  • 11.4.4 Genscript Biotech Corp Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.4.5 Genscript Biotech Corp Recent Development
  • 11.5 Synbio Technologies
  • 11.5.1 Synbio Technologies Company Detail
  • 11.5.2 Synbio Technologies Business Overview
  • 11.5.3 Synbio Technologies Gene Subcloning Service Introduction
  • 11.5.4 Synbio Technologies Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.5.5 Synbio Technologies Recent Development
  • 11.6 Bio Basic
  • 11.6.1 Bio Basic Company Detail
  • 11.6.2 Bio Basic Business Overview
  • 11.6.3 Bio Basic Gene Subcloning Service Introduction
  • 11.6.4 Bio Basic Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.6.5 Bio Basic Recent Development
  • 11.7 Bioneer Corporation
  • 11.7.1 Bioneer Corporation Company Detail
  • 11.7.2 Bioneer Corporation Business Overview
  • 11.7.3 Bioneer Corporation Gene Subcloning Service Introduction
  • 11.7.4 Bioneer Corporation Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.7.5 Bioneer Corporation Recent Development
  • 11.8 Applied Biological Materials
  • 11.8.1 Applied Biological Materials Company Detail
  • 11.8.2 Applied Biological Materials Business Overview
  • 11.8.3 Applied Biological Materials Gene Subcloning Service Introduction
  • 11.8.4 Applied Biological Materials Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.8.5 Applied Biological Materials Recent Development
  • 11.9 Takara Bio
  • 11.9.1 Takara Bio Company Detail
  • 11.9.2 Takara Bio Business Overview
  • 11.9.3 Takara Bio Gene Subcloning Service Introduction
  • 11.9.4 Takara Bio Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.9.5 Takara Bio Recent Development
  • 11.10 Canvax Biotech
  • 11.10.1 Canvax Biotech Company Detail
  • 11.10.2 Canvax Biotech Business Overview
  • 11.10.3 Canvax Biotech Gene Subcloning Service Introduction
  • 11.10.4 Canvax Biotech Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.10.5 Canvax Biotech Recent Development
  • 11.11 Codex DNA
  • 11.11.1 Codex DNA Company Detail
  • 11.11.2 Codex DNA Business Overview
  • 11.11.3 Codex DNA Gene Subcloning Service Introduction
  • 11.11.4 Codex DNA Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.11.5 Codex DNA Recent Development
  • 11.12 Azenta US
  • 11.12.1 Azenta US Company Detail
  • 11.12.2 Azenta US Business Overview
  • 11.12.3 Azenta US Gene Subcloning Service Introduction
  • 11.12.4 Azenta US Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.12.5 Azenta US Recent Development
  • 11.13 Macrogen
  • 11.13.1 Macrogen Company Detail
  • 11.13.2 Macrogen Business Overview
  • 11.13.3 Macrogen Gene Subcloning Service Introduction
  • 11.13.4 Macrogen Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.13.5 Macrogen Recent Development
  • 11.14 InvivoGen
  • 11.14.1 InvivoGen Company Detail
  • 11.14.2 InvivoGen Business Overview
  • 11.14.3 InvivoGen Gene Subcloning Service Introduction
  • 11.14.4 InvivoGen Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.14.5 InvivoGen Recent Development
  • 11.15 BioCat GmbH
  • 11.15.1 BioCat GmbH Company Detail
  • 11.15.2 BioCat GmbH Business Overview
  • 11.15.3 BioCat GmbH Gene Subcloning Service Introduction
  • 11.15.4 BioCat GmbH Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.15.5 BioCat GmbH Recent Development
  • 11.16 BEX Co., Ltd
  • 11.16.1 BEX Co., Ltd Company Detail
  • 11.16.2 BEX Co., Ltd Business Overview
  • 11.16.3 BEX Co., Ltd Gene Subcloning Service Introduction
  • 11.16.4 BEX Co., Ltd Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.16.5 BEX Co., Ltd Recent Development
  • 11.17 Lonza Group
  • 11.17.1 Lonza Group Company Detail
  • 11.17.2 Lonza Group Business Overview
  • 11.17.3 Lonza Group Gene Subcloning Service Introduction
  • 11.17.4 Lonza Group Revenue in Gene Subcloning Service Business (2017-2022)
  • 11.17.5 Lonza Group Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Summary:
      Get latest Market Research Reports on Gene Subcloning Service. Industry analysis & Market Report on Gene Subcloning Service is a syndicated market report, published as Global Gene Subcloning Service Market Research Report 2022. It is complete Research Study and Industry Analysis of Gene Subcloning Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,604.20
      5,208.40
      2,958.00
      5,916.00
      420,065.00
      840,130.00
      236,669.00
      473,338.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report